Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in… GlobalData Dec 11, 2024 Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India EP News Bureau Nov 28, 2024 Toripalimab is an immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat… EP News Bureau Sep 11, 2020 It is the first anti-PD-1 antibody from China to receive BTD
